This session will serve to provide a summary of key points and highlights of the conference. Thoughts on future challenges and directions will be discussed.

Learning Objective : At the conclusion of this session, participants should be able to: Summarize key takeaways from the conference
Discuss future challenges and directions for complex generic drug-device combination products

Have an account?

DIA/FDA Complex Generic Drug-Device Combination Products Conference

Session 8: Closing Remarks

Session Chair(s)

Robert A. Lionberger, PhD

Learning Objective : At the conclusion of this session, participants should be able to: Summarize key takeaways from the conferenceDiscuss future challenges and directions for complex generic drug-device combination products

Be informed and stay engaged.

Learning Objective : At the conclusion of this session, participants should be able to: Summarize key takeaways from the conference
Discuss future challenges and directions for complex generic drug-device combination products